Debt-to-equity of Augmedix, Inc. from 30 Sep 2019 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Augmedix, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Jun 2024.
  • Augmedix, Inc. Debt-to-equity for the quarter ending 30 Jun 2024 was 322%, a 80% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Augmedix, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 322% -1272% -80% 30 Jun 2024
Q1 2024 360% -428% -54% 31 Mar 2024
Q4 2023 642% +325% +103% 31 Dec 2023
Q3 2023 4945% +4753% +2478% 30 Sep 2023
Q2 2023 1594% +1356% +570% 30 Jun 2023
Q1 2023 788% +429% +119% 31 Mar 2023
Q4 2022 317% -655% -67% 31 Dec 2022
Q3 2022 192% +1265% 30 Sep 2022
Q2 2022 238% +338% 30 Jun 2022
Q1 2022 359% +394% 31 Mar 2022
Q4 2021 972% +984% 31 Dec 2021
Q3 2021 -1073% -1063% -11063% 30 Sep 2021
Q2 2021 -100% -87% -660% 30 Jun 2021
Q1 2021 -35% -15% -74% 31 Mar 2021
Q4 2020 -12% +30% +72% 31 Dec 2020
Q3 2020 -10% +96% +91% 30 Sep 2020
Q2 2020 -13% 30 Jun 2020
Q1 2020 -20% 31 Mar 2020
Q4 2019 -42% 31 Dec 2019
Q3 2019 -106% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.